DK1939204T3 - Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf - Google Patents

Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf

Info

Publication number: DK1939204T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; same; composition containing; medical use; condensed heterocyclic
Prior art date: 2005-10-19

Application number

DK06811925.4T

Other languages

English (en)

Other versions

DK1939204T6 (da

Inventor

Kohsuke Ohno

Takashi Miyagi

Tomonaga Ozawa

Nobuhiko Fushimi

Original Assignee

Kissei Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-19

Filing date

2006-10-17

Publication date

2013-03-11

2006-10-17 Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical

2013-03-11 Application granted granted Critical

2013-03-11 Publication of DK1939204T3 publication Critical patent/DK1939204T3/da

2022-09-05 Publication of DK1939204T6 publication Critical patent/DK1939204T6/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Pregnancy & Childbirth (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK06811925.4T 2005-10-19 2006-10-17 Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf DK1939204T6 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2005304395		2005-10-19
JP2006147019		2006-05-26
PCT/JP2006/320681 WO2007046392A1 (ja)	2005-10-19	2006-10-17	縮合複素環誘導体、それを含有する医薬組成物及びその医薬用途

Publications (2)

Publication Number	Publication Date
DK1939204T3 true DK1939204T3 (da)	2013-03-11
DK1939204T6 DK1939204T6 (da)	2022-09-05

Family

ID=37962485

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06811925.4T DK1939204T6 (da)	2005-10-19	2006-10-17	Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf

Country Status (21)

Country	Link
US (1)	US9040693B2 (da)
EP (1)	EP1939204B3 (da)
JP (2)	JP4955566B2 (da)
KR (1)	KR101384132B1 (da)
AU (1)	AU2006305271B2 (da)
BR (1)	BRPI0617436B8 (da)
CA (1)	CA2624492C (da)
CY (1)	CY1113898T1 (da)
DK (1)	DK1939204T6 (da)
ES (1)	ES2398917T7 (da)
HK (1)	HK1125110A1 (da)
IL (1)	IL190754A (da)
NL (1)	NL301202I2 (da)
NO (1)	NO343185B1 (da)
NZ (1)	NZ567300A (da)
PL (1)	PL1939204T6 (da)
PT (1)	PT1939204E (da)
RU (1)	RU2418803C2 (da)
SI (1)	SI1939204T1 (da)
TW (1)	TWI400074B (da)
WO (1)	WO2007046392A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5735799B2 (ja) *	2007-04-06	2015-06-17	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	ゴナドトロピン放出ホルモン受容体拮抗薬およびそれに関連する方法
PE20090236A1 (es)	2007-04-06	2009-03-13	Neurocrine Biosciences Inc	Antagonistas de los receptores de la hormona liberadora de gonadotropina y procedimientos relacionados con ellos
EP2145889A4 (en) *	2007-04-18	2012-04-18	Kissei Pharmaceutical	HETEROCYCLIC FUSED CORE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE, AND USE OF THE COMPOSITION FOR MEDICAL PURPOSES
EP2147922B1 (en) *	2007-04-18	2017-08-02	Kissei Pharmaceutical Co., Ltd.	Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
NZ601684A (en)	2010-02-10	2013-08-30	Kissei Pharmaceutical	Salt of fused heterocyclic derivative and crystal thereof
CA2882879A1 (en)	2012-08-24	2014-02-27	Takeda Pharmaceutical Company Limited	Heterocyclic compound
JP6268093B2 (ja) *	2012-09-14	2018-01-24	キッセイ薬品工業株式会社	縮合複素環誘導体の製造方法およびその製造中間体
CN106132931B (zh) *	2014-01-06	2019-08-02	百时美施贵宝公司	碳环砜RORγ调节剂
TWI746613B (zh)	2016-08-08	2021-11-21	日商橘生藥品工業股份有限公司	子宮內膜病症治療劑之用法及用量
EP4011386A1 (en) *	2017-01-31	2022-06-15	Veru Inc.	Compositions and methods for long term release of gonadotropin-releasing hormone (gnrh) antagonists
AU2018280742B2 (en)	2017-06-05	2023-12-21	Kissei Pharmaceutical Co., Ltd.	Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis
JP7292566B2 (ja)	2017-06-05	2023-06-19	キッセイ薬品工業株式会社	子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画
HRP20220510T1 (hr) *	2018-01-30	2022-05-27	Incyte Corporation	Postupci za pripravu (1-(3-fluoro-2-(trifluorometil)izonikotinil) piperidin-4-ona)
AU2019373349B2 (en)	2018-10-29	2025-01-09	Kissei Pharmaceutical Co., Ltd.	Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis
JP7459086B2 (ja)	2018-11-07	2024-04-01	キッセイ薬品工業株式会社	エストロゲン依存性障害の治療のための組成物及び方法
KR20220061120A (ko)	2019-08-08	2022-05-12	옵스에파 에스에이	에스트로겐-의존성 장애 치료용 조성물 및 방법
US20220288154A1 (en) *	2019-08-08	2022-09-15	ObsEva S.A.	Gnrh antagonists for the treatment of estrogen-dependent disorders
TWI791388B (zh) *	2021-02-23	2023-02-01	大陸商南京明德新藥研發有限公司	多并環取代的5-羧酸噻吩并嘧啶二酮類化合物及其應用
TWI796144B (zh) *	2021-02-23	2023-03-11	大陸商南京明德新藥研發有限公司	噻吩並嘧啶二酮類化合物及其應用
JPWO2023149546A1 (da)	2022-02-04	2023-08-10
CN119698409A (zh) *	2022-08-16	2025-03-25	深圳市康哲生物科技有限公司	一种噻吩并嘧啶酮衍生物的盐型及晶型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2192283A1 (en) *	1995-12-08	1997-06-09	Nobuhiro Suzuki	Prolactin production inhibitory agent
US6015789A (en) *	1996-04-30	2000-01-18	Takeda Chemical Industries, Ltd.	Combined use of GnRH agonist and antagonist
EP0901489A1 (en) *	1996-05-20	1999-03-17	Merck & Co., Inc.	Antagonists of gonadotropin releasing hormone
GB0124627D0 (en)	2001-10-15	2001-12-05	Smithkline Beecham Plc	Novel compounds
WO2005049613A1 (en) *	2003-11-14	2005-06-02	Merck Sharp & Dohme Limited	Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
AU2004303876A1 (en) *	2003-12-19	2005-07-07	Merck & Co., Inc.	Mitotic kinesin inhibitors
JPWO2006083005A1 (ja)	2005-02-03	2008-06-26	武田薬品工業株式会社	縮合ピリミジン誘導体およびその用途

2006
- 2006-10-17 DK DK06811925.4T patent/DK1939204T6/da active
- 2006-10-17 ES ES06811925T patent/ES2398917T7/es active Active
- 2006-10-17 PL PL06811925.4T patent/PL1939204T6/pl unknown
- 2006-10-17 SI SI200631557T patent/SI1939204T1/sl unknown
- 2006-10-17 JP JP2007540993A patent/JP4955566B2/ja active Active
- 2006-10-17 AU AU2006305271A patent/AU2006305271B2/en active Active
- 2006-10-17 CA CA2624492A patent/CA2624492C/en active Active
- 2006-10-17 RU RU2008119462/04A patent/RU2418803C2/ru active
- 2006-10-17 US US12/089,674 patent/US9040693B2/en active Active
- 2006-10-17 WO PCT/JP2006/320681 patent/WO2007046392A1/ja active Application Filing
- 2006-10-17 PT PT68119254T patent/PT1939204E/pt unknown
- 2006-10-17 NZ NZ567300A patent/NZ567300A/en unknown
- 2006-10-17 BR BRPI0617436A patent/BRPI0617436B8/pt active IP Right Grant
- 2006-10-17 EP EP06811925.4A patent/EP1939204B3/en active Active
- 2006-10-17 KR KR1020087010997A patent/KR101384132B1/ko active Active
- 2006-10-19 TW TW095138520A patent/TWI400074B/zh active
2008
- 2008-04-09 IL IL190754A patent/IL190754A/en active IP Right Grant
- 2008-05-19 NO NO20082249A patent/NO343185B1/no unknown
2009
- 2009-04-09 HK HK09103380.3A patent/HK1125110A1/xx unknown
2012
- 2012-01-19 JP JP2012008680A patent/JP5319797B2/ja active Active
2013
- 2013-04-02 CY CY20131100276T patent/CY1113898T1/el unknown
2022
- 2022-11-01 NL NL301202C patent/NL301202I2/nl unknown

Also Published As

Publication number	Publication date
SI1939204T1 (sl)	2013-05-31
JP4955566B2 (ja)	2012-06-20
TWI400074B (zh)	2013-07-01
AU2006305271B2 (en)	2011-11-17
RU2418803C2 (ru)	2011-05-20
NL301202I1 (nl)	2022-11-09
EP1939204A4 (en)	2010-09-01
NO20082249L (no)	2008-07-18
AU2006305271A1 (en)	2007-04-26
NO343185B1 (no)	2018-11-26
IL190754A0 (en)	2008-11-03
US9040693B2 (en)	2015-05-26
CA2624492C (en)	2014-02-18
DK1939204T6 (da)	2022-09-05
EP1939204B3 (en)	2022-08-24
US20090325900A1 (en)	2009-12-31
CA2624492A1 (en)	2007-04-26
EP1939204A1 (en)	2008-07-02
KR20080063827A (ko)	2008-07-07
TW200732309A (en)	2007-09-01
PL1939204T3 (pl)	2013-06-28
JPWO2007046392A1 (ja)	2009-04-23
BRPI0617436A2 (pt)	2011-07-26
WO2007046392A1 (ja)	2007-04-26
BRPI0617436B1 (pt)	2021-04-06
PT1939204E (pt)	2013-03-14
NZ567300A (en)	2010-11-26
JP5319797B2 (ja)	2013-10-16
IL190754A (en)	2012-10-31
EP1939204B1 (en)	2013-01-02
NL301202I2 (nl)	2023-01-24
RU2008119462A (ru)	2009-11-27
BRPI0617436B8 (pt)	2021-05-25
KR101384132B1 (ko)	2014-04-10
CY1113898T1 (el)	2016-07-27
HK1125110A1 (en)	2009-07-31
PL1939204T6 (pl)	2024-03-25
JP2012102140A (ja)	2012-05-31
ES2398917T3 (es)	2013-03-22
ES2398917T7 (es)	2022-10-26

Publication	Publication Date	Title
DK1939204T3 (da)	2013-03-11	Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf
NO20081604L (no)	2008-07-03	Nitrogeninneholdende heterocyklisk forbindelse og farmasøytisk anvendelse derav
IL225206A (en)	2017-11-30	A derivative of multinuclear carbamoylpyridone, its pharmaceutical composition and its use
IL199397A (en)	2014-07-31	Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
IL192184A0 (en)	2009-02-11	Heterocyclic derivatives and pharmaceutical compositions containing the same
EP1876178A4 (en)	2011-09-07	CYANOPYRIDINE DERIVATIVE AND THE USE THEREOF AS A MEDICAMENT
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
DK2207773T3 (da)	2012-09-10	Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
HK1099556A1 (en)	2007-08-17	Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
NO345062B1 (no)	2020-09-14	4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy) pyrimidinbaserte forbindelser og anvendelse derav
DK1928879T3 (da)	2013-05-21	Kondenserede heterocykliske forbindelser og anvendelse heraf som kinase-modulatorer
BRPI0508259A (pt)	2007-07-31	derivado heterocìclico fundido, composição medicinal contendo o mesmo, e uso medicinal do mesmo
BRPI0810523A2 (pt)	2014-10-21	Derivado heterocíclico de 5 membros e uso do mesmo para propósitos médicos.
IL192298A (en)	2016-02-29	Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
IL191141A0 (en)	2008-12-29	Heterocyclic compounds and pharmaceutical compositions containing the same
IL186665A0 (en)	2008-01-20	Heterocyclic compounds and pharmaceutical compositions containing the same
IL187434A0 (en)	2008-02-09	Heterocyclic compounds and pharmaceutical compositions containing the same
BRPI0815190A2 (pt)	2015-03-31	Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
DK2079485T3 (da)	2012-08-06	Phenylpropionamidforbindelser og anvendelsen deraf
DK1885716T3 (da)	2013-02-11	Thiazolderivater og anvendelse deraf
DK2234968T3 (da)	2013-06-17	(aza)indolderivat substitueret i position 5, farmaceutisk sammensætning omfattende det, mellemliggende forbindelser og fremstillingsproces dertil
ATE420081T1 (de)	2009-01-15	Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
DK1707564T3 (da)	2008-01-21	Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
BRPI0819202A2 (pt)	2015-05-05	Derivado heterocíclico, e, composição farmacêutica
DK1940840T3 (da)	2010-11-22	6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf